{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T14:05:52Z","timestamp":1653314752824},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1016\/s0149-2918(01)80098-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:23:54Z","timestamp":1027617834000},"page":"1145-1165","source":"Crossref","is-referenced-by-count":3,"title":["Platelet glycoprotein IIb\/IIIa\u2014receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: a review"],"prefix":"10.1016","volume":"23","author":[{"given":"Kate M.","family":"Truong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwadwo","family":"Amankwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"Kucukarslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0149-2918(01)80098-9_BIB1","unstructured":"Heart and Stroke A\u2013Z Guide: 2001 Heart and Stroke Statistical Update. Available at: http:\/\/www.americanheart.org. Accessed May 2001."},{"key":"10.1016\/S0149-2918(01)80098-9_BIB2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/heart.83.3.361","article-title":"The pathophysiology of acute coronary syndromes","volume":"83","author":"Davies","year":"2000","journal-title":"Heart"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB3","first-page":"224","article-title":"Thrombus formation on atherosclerotic plaques: Pathogenesis and clinical consequences","volume":"134","author":"Rauch","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","article-title":"ACC\/AHA guidelines for the management of patients with unstable angina and non\u2014ST-segment elevation myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)","volume":"36","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0735-1097(00)00554-4","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade in coronary artery disease","volume":"35","author":"Lincoff","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1345\/aph.18327","article-title":"The evolving role of platelet glycoprotein IIb\/IIIa inhibitors in the management of acute coronary syndromes","volume":"33","author":"Stringer","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) trial\u2014phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non\u2014Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB13","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","article-title":"International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. Platelet IIb\/IIIa Antagonism for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB14","first-page":"956","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation","volume":"33","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(94)90007-8","article-title":"Randomised trial of coronary intervention with antibody against platelet IIb\/IIIa integrin for reduction of clinical restenosis: Results at 6 months","volume":"343","author":"Topol","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.278.6.479","article-title":"Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. Evaluation of Platelet IIb\/IIIa Inhibition for Prevention of Ischemic Complication","volume":"278","author":"Topol","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.98.8.734","article-title":"Randomized, placebo-controlled trial of platelet glycoprotein IIb\/IIIa blockade with primary angioplasty for acute myocardial infarction","volume":"98","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB20","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/01.CIR.91.8.2151","article-title":"Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb\/IIIa blocker Integrelin in elective coronary intervention","volume":"91","author":"Tcheng","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB21","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","article-title":"Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrelin to Minimise Platelet Aggregation and Coronary Thrombosis\u2014II","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","article-title":"Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty\u2014controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0735-1097(00)00805-6","article-title":"Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000","volume":"36","author":"Kleiman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB25","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","article-title":"1999 Update: ACC\/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)","volume":"34","author":"Ryan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB27","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/01.CIR.101.24.2788","article-title":"Trial of abciximab with and without low-dose reteplase for acute myocardial infarction","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.95.4.846","article-title":"Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb\/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial","volume":"95","author":"Ohman","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9149(96)00382-7","article-title":"Incidence and importance of Thrombolysis in Myocardial Infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction","volume":"78","author":"Laster","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9149(00)01427-2","article-title":"Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention","volume":"87","author":"Brown","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB31","year":"2000"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0167-5273(99)00171-0","article-title":"Combination therapy with tirofiban and enoxaparin in acute coronary syndromes","volume":"71","author":"Cohen","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB33","first-page":"1A","article-title":"Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: \u201cNICE guys finish first\u201d","volume":"12","author":"Kereiakes","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.CIR.101.4.366","article-title":"Cost-effectiveness of platelet glycoprotein IIb\/IIIa inhibition with eptifibatide in patients with non\u2014ST-elevation acute coronary syndromes","volume":"101","author":"Mark","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S0149-2918(01)80098-9_BIB35","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(99)10018-7","article-title":"Outcomes at 1 year and economic implications of platelet glycoprotein IIb\/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial. Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting","volume":"354","author":"Topol","year":"1999","journal-title":"Lancet"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291801800989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291801800989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:24:45Z","timestamp":1556151885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291801800989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0149291801800989"],"URL":"https:\/\/doi.org\/10.1016\/s0149-2918(01)80098-9","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}